These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 18985631)

  • 1. Use of genome typing in breast cancer.
    Rubio IT
    J Surg Oncol; 2009 Jan; 99(1):3-4. PubMed ID: 18985631
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional analysis of the breast cancer genome.
    Ellis MJ
    J Clin Oncol; 2006 Apr; 24(11):1649-50. PubMed ID: 16505408
    [No Abstract]   [Full Text] [Related]  

  • 3. International randomized trials' attention to locoregional breast cancer control and promise of personal genomics and whole-genome scans for personalized approaches.
    Zografos G; Roukos DH
    Ann Surg Oncol; 2009 Jan; 16(1):222-3. PubMed ID: 18989725
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomic profiling of breast cancer.
    Pandey A; Singh AK; Maurya SK; Rai R; Tewari M; Kumar M; Shukla HS
    J Surg Oncol; 2009 May; 99(6):386-92. PubMed ID: 19235775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.
    Selcuklu SD; Yakicier MC; Erson AE
    Cancer Genet Cytogenet; 2009 Feb; 189(1):15-23. PubMed ID: 19167607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome copy number variation and breast cancer risk.
    Tchatchou S; Burwinkel B
    Cytogenet Genome Res; 2008; 123(1-4):183-7. PubMed ID: 19287154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of breast cancer in the genome era.
    Morrow PK; Hortobagyi GN
    Annu Rev Med; 2009; 60():153-65. PubMed ID: 19630569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer.
    Roukos DH
    J Clin Oncol; 2009 Mar; 27(8):1337-8; author reply 1338-9. PubMed ID: 19188673
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome-based diagnostics and predictive tools: a new epoch for breast cancer management.
    Ziogas DE; Baltogiannis G; Spiliotis J; Tzaphlidou M; Roukos DH
    Future Oncol; 2012 Oct; 8(10):1211-4. PubMed ID: 23130921
    [No Abstract]   [Full Text] [Related]  

  • 12. Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions.
    Yu KD; Di GH; Fan L; Shao ZM
    Breast Cancer Res Treat; 2009 Oct; 117(3):675-7. PubMed ID: 19242790
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of the mitochondrial microsatellite 303-315 in breast cancer in Tunisia].
    Yacoubi-Loueslati B; Troudi W; Baccar A; Cherni L; Rhomdhane KB; Elgaaied AB
    Bull Cancer; 2009 Mar; 96(3):337-42. PubMed ID: 19318312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of breast cancer: toward the individualization of therapy.
    Chang JC; Hilsenbeck SG; Fuqua SA
    Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
    Marsh S; Liu G
    Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
    Gaafar A; Aljurf MD; Al-Sulaiman A; Iqniebi A; Manogaran PS; Mohamed GE; Al-Sayed A; Alzahrani H; Alsharif F; Mohareb F; Ajarim D; Tabakhi A; Al-Hussein K
    Exp Hematol; 2009 Jul; 37(7):838-48. PubMed ID: 19446661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds.
    Wang YA; Johnson SK; Brown BL; Dobson PR
    Oncol Rep; 2009 Feb; 21(2):437-42. PubMed ID: 19148520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.